Table 2 Clinical characteristics of MM patients with MRONJ
No. | Stage (sign) | locLocation | Etiologic factor | BP types (duration in months) | Treatment | Outcomes (stage) |
|---|---|---|---|---|---|---|
1 | II (Bone exposure, pus discharge, pain) | Mandible molar | Denture irritation | Zoledronate, pamidronate (19) | I&D, antibiotics, dressing, biopsy | Bone exposure (stage I) |
2 | II (Bone exposure, pus discharge, pain) | Mandible molar | Pontic irritation | Zoledronate, pamidronate (19) | Antibiotics, dressing, biopsy | Bone exposure (stage I) |
3 | II (Bone exposure, pus discharge, pain) | Mandible molar | Tooth extraction | Zoledronate (15) | I&D, antibiotics, dressing | Bone exposure (stage I) |
4 | II (Bone exposure, pain) | Mandible molar | Tooth extraction | Zoledronate, Pamidronate (69) | Antibiotics, Dressing | Bone exposure (stage I) |
5 | II (Bone exposure, pus discharge, pain) | Mandible molar | Tooth extraction | Zoledronate, pamidronate (11) | Saucerization I&D, antibiotics, dressing | No follow-up |
6 | I (Bone exposure) | Mandible molar | Spontaneous | Zoledronate, pamidronate (25) | Antibiotics, dressing | Bone exposure (stage I) |
7 | II (Bone exposure, pus discharge, pain) | Maxilla molar | Gingival curettage | Zoledronate, pamidronate (40) | Antibiotics, dressing | Bone exposure with pain (stage II) |
8 | III (Pain, Osteolytic lesion on Mn. Basal bone) | Mandible molar | Tooth extraction | Pamidronate (8) | Antibiotics, dressing | No f/u |
9 | I (Bone exposure) | Mandible molar | Tooth extraction | Zoledronate, pamidronate (17) | Antibiotics, dressing, biopsy | Bone exposure state (died due to systemic disease) |